Alexcure Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
as on 17-11-2024
- Revenue 20.06%
(FY 2023)
- Profit 11.02%
(FY 2023)
- Ebitda -4954.37%
(FY 2023)
- Net Worth 125.92%
(FY 2023)
- Total Assets 240.74%
(FY 2023)
About Alexcure Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M.
Hardeep Nimber, Rohit Chauhan, and Mohit Kumar serve as directors at the Company.
- CIN/LLPIN
U24299CH2020PTC043215
- Company No.
043215
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Alexcure Lifesciences Private Limited offer?
Alexcure Lifesciences Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Common Disease Medicines, Antihistamines, Anti Infective Drugs & Medicines, Antibacterial Drugs, Cardiovascular Drugs & Medication, Diabetes Medicine.
Who are the key members and board of directors at Alexcure Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hardeep Nimber  | Director | 12-Sep-2020 | Current |
| Rohit Chauhan | Director | 12-Sep-2020 | Current |
| Mohit Kumar | Director | 12-Sep-2020 | Current |
Financial Performance of Alexcure Lifesciences.
Alexcure Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.06% increase. The company also saw a substantial improvement in profitability, with a 11.02% increase in profit. The company's net worth Soared by an impressive increase of 125.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alexcure Lifesciences?
Unlock access to Alexcure Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Brotkin Lifesciences Private LimitedActive 2 years 4 months
Hardeep Nimber, Rohit Chauhan and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 01 Jun 2023 | ₹2.50 M | Open |
How Many Employees Work at Alexcure Lifesciences?
Alexcure Lifesciences has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alexcure Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alexcure Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
